Hematologist
CION Cancer Clinics
SLL and CLL: what is the difference? | CION Cancer Clinics
SLL and CLL are the same disease with two names. When the abnormal B cells are found mainly in the blood, it is called chronic lymphocytic leukaemia (CLL). When they sit mainly in the lymph nodes and the blood count stays below the guideline cut-off, it is small lymphocytic lymphoma (SLL). Both are staged, watched and treated the same way. This page explains how the name is chosen and what matters more. At CION Cancer Clinics, our haematology team plans myeloma and lymphoma care with you, discussed at a tumour board and explained in plain words.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Are SLL and CLL the same disease?
- How do SLL and CLL differ on paper?
- How do doctors decide whether it is SLL or CLL?
- What matters more than whether it is called SLL or CLL?
- What do people misunderstand about SLL and CLL?
- Is treatment different for SLL and CLL?
- Which questions should you ask your haematologist?
- Common questions about SLL and CLL
The short answer
Are SLL and CLL the same disease?
Yes. Small lymphocytic lymphoma (SLL) and chronic lymphocytic leukaemia (CLL) are the same disease, made of the same abnormal white cells. The name only tells you where most of those cells are found: mainly in the blood for CLL, mainly in the lymph nodes for SLL.
How the name is chosen
The cells are a type of white blood cell called a B lymphocyte. When the blood holds a large number of these cells, the diagnosis is CLL. When the blood count of these cells stays below 5 × 10⁹/L, which is 5,000 per microlitre, but lymph nodes, the spleen or the liver are enlarged by them, the diagnosis is SLL. International guidelines use this cut-off. Reference ranges differ between laboratories, and one result is always read with repeat tests and the examination.
Why this matters less than you might think
Because they are one disease, SLL and CLL are staged, monitored and treated in the same way. Many haematologists now write "CLL/SLL" on the report. The label can even change over time, if cells spill from the nodes into the blood. That change does not by itself mean the illness has become worse.
Side by side
How do SLL and CLL differ on paper?
SLL
CLL
Disease sits mainly in the lymph nodes, spleen or liver
Disease is seen mainly in the blood and bone marrow
Blood count of abnormal B cells is below the guideline cut-off
Blood count of abnormal B cells is at or above the cut-off
Usually confirmed by a lymph node biopsy
Usually confirmed by a blood test called flow cytometry
Staged like a lymphoma, often with a scan
Staged with blood counts and examination
Treated the same way as CLL
Treated the same way as SLL
Getting to the name
How do doctors decide whether it is SLL or CLL?
A full blood count
Often the first clue is a raised lymphocyte count on a routine test. In SLL the count may be normal, and the first clue is a lump in the neck or armpit instead.
Flow cytometry
A blood sample is run through a machine that reads markers on the surface of each cell. It shows whether the lymphocytes are all from one abnormal family, and counts them.
A lymph node biopsy
If the blood count is low but nodes are large, a node or a core of tissue is taken. The pathologist looks at the pattern and runs markers, called immunohistochemistry, to confirm SLL.
Scans and extra tests
A CT or PET-CT scan may map the nodes. Tests on the cells' genes, such as TP53 and IGHV, help plan treatment for both SLL and CLL.
Not sure whether this applies to you?
Ask an oncologistBeyond the label
What matters more than whether it is called SLL or CLL?
These are the things your haematologist looks at when deciding whether to treat, and how.
Stage
How much of the body is involved, and whether blood counts such as haemoglobin and platelets have dropped. Rai and Binet are the two staging systems you may see.
Symptoms
Drenching night sweats, fevers, weight loss, extreme tiredness or painful, growing nodes. These often mean treatment is due.
Gene changes in the cells
Changes such as TP53 mutation or deletion 17p change which medicines work well, and are checked before treatment starts.
You may see
- IGHV mutated or unmutated
- del(17p) or TP53
- del(11q)
Your overall health
Age alone does not decide treatment. Heart health, kidney function, other medicines and what you want from treatment all shape the plan. A fit person in their seventies may be offered the same medicines as someone much younger, while a frail younger person may not.
Commonly believed
What do people misunderstand about SLL and CLL?
"Leukaemia is worse than lymphoma, so CLL is the more serious one."
The two words describe where the same cells sit, not how dangerous they are. SLL and CLL at the same stage, with the same gene results, behave in much the same way.
"The report changed from SLL to CLL, so it is spreading fast."
Cells can move from nodes into blood over time. A name change alone is not a sign of danger. Your haematologist will look at the trend of counts, symptoms and scans instead.
"If it is cancer, treatment must start straight away."
Many people with early SLL or CLL have no symptoms and are safely watched without treatment for a long time. Starting early, before it is needed, has not been shown to help most people.
"A lump that grows suddenly is just more of the same disease."
Usually it is, but rarely SLL or CLL changes into a faster lymphoma, called Richter transformation. Rapid growth, high fevers or a sudden change in how you feel should be reported promptly.
Treatment
Is treatment different for SLL and CLL?
No. Treatment follows the same guidelines for both. Many people start with watch and wait, which means regular check-ups and blood tests without medicine, until symptoms or falling counts show that treatment is needed.
What treatment may involve
Today most people who need treatment are offered targeted medicines rather than traditional chemotherapy. These include BTK inhibitors, such as ibrutinib, acalabrutinib or zanubrutinib, taken as tablets, and venetoclax combined with an antibody such as obinutuzumab. Radiotherapy is sometimes used for SLL confined to one area of nodes. Which one suits you depends on your gene results, heart health and other medicines.
Who a given option does not suit
BTK inhibitors may not suit people with certain heart rhythm problems or those on blood thinners. Venetoclax needs careful monitoring of the kidneys at the start. Chemotherapy combinations work poorly when TP53 is changed, so are usually avoided then.
What this page cannot tell you
It cannot tell you your stage, whether you need treatment now or what your outlook is. Your haematologist builds that picture from your own reports.
Take this to your appointment
Which questions should you ask your haematologist?
- Is my diagnosis written as SLL, CLL or CLL/SLL, and why?
- What stage am I, and what does that mean for me?
- Have IGHV and TP53 been tested, or should they be?
- Do I need treatment now, or is watch and wait right for me?
- Which symptoms should make me call before my next visit?
- How often will I need blood tests and reviews?
Questions we are asked
Common questions about SLL and CLL
Why does my report say CLL/SLL together?
Because the World Health Organization treats them as one disease with two ways of showing itself. Writing both names avoids confusion if the pattern shifts later. It also reminds every doctor who reads the report that the same staging, tests and treatment guidelines apply, whichever name fits best today.
Can SLL turn into CLL?
Yes, the label can change. If the abnormal cells in the blood rise above the guideline cut-off, a diagnosis of SLL may later be called CLL. This reflects where the cells are found, not a new illness. Your haematologist will judge progress by symptoms, blood counts and scans together.
Is SLL or CLL a slow-growing cancer?
In most people, yes. It is grouped with the indolent, or slow-growing, lymphomas. Some people never need treatment. Others need it within a few years. A smaller group has faster disease from the start, often linked to gene changes such as TP53. Your own tests show which group you are likely in.
Do I need a bone marrow biopsy?
Not always. Many people with CLL are diagnosed from a blood test alone. A bone marrow biopsy may be advised before treatment, when blood counts fall without a clear reason, or in a clinical trial. Ask your haematologist why it is being recommended in your case.
Is SLL or CLL inherited? Should my children be tested?
It is not passed on in a simple way, but close relatives have a somewhat higher chance of it than other people. Routine testing of healthy family members is not usually advised. If your children are worried, they can mention the family history to their own doctor at a routine check-up.
Does SLL or CLL make infections more likely?
Yes. The disease weakens the immune system even before treatment. Report any fever promptly. Ask your haematologist about vaccines, including the flu and pneumonia vaccines, and avoid live vaccines unless your team approves them. Good hand hygiene helps during festivals and crowded travel.
Is treatment for SLL or CLL covered by Aarogyasri?
Many parts of care may be covered by Aarogyasri, PM-JAY, CGHS, ECHS, EHS or cashless insurance. Coverage for newer tablets can be limited, and scheme rules change. Check the current rules with your scheme or insurer, and ask the hospital to confirm before treatment begins.
Where can I get my diagnosis reviewed in Hyderabad?
CION's haematology team, which includes haematologist Dr. Basudev Pokhrel, reviews blood cancer reports and presents cases to a tumour board. Bring your flow cytometry report, biopsy report, scans and blood counts. The team coordinates any specialised gene tests with qualified laboratories.
Your Haematologist
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- National Cancer Institute — Chronic Lymphocytic Leukemia Treatment (PDQ), Health Professional Version
- American Cancer Society — Chronic lymphocytic leukemia
- NHS — Chronic lymphocytic leukaemia
- Leukemia & Lymphoma Society — Chronic lymphocytic leukemia
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Talk to us
Confused by CLL/SLL on your report?
Share your reports with us. CION's haematology team will explain the diagnosis, the stage and whether treatment is needed now. One helpline serves every CION centre.